Wonderful Capital Biotechnology Group's legal director Yifei Xu attended the Business Symposium on 3D skin modelling and 3D skin regeneration technology at the University of Wollongong on August 19th.
Key participants included Kristin Heimann, (Professor at the MBCRC), Gordon Wallace (Trustee and Professor at the University of Wollongong) and other experienced professionals.
Researchers from the University of Wollongong, including Eileen Wallace, Johnson Chung, Sepidar Sayyar, Xiao Liu, Anna Kulaga, and Kalani Ruberu, led by Professor Gordon Wallace, have made a series of breakthroughs in the field of 3D skin.
The 3D skin project is divided into two items. Firstly, is the 3D skin model technology, which researches the printing of skin tissue through high-end 3D printing technology so that the skin model can completely replace human skin tissue. The other is 3D skin regeneration technology, which enables printed skin to grow on the human body and heal with human skin.
This project opens up a new clinical experiment method for the future biomedical field so that 3D skin models can replace animal clinical trials. Furthermore, it can become a universal skin clinical trial methodology. At the same time, it offers entirely new medical technology that can provide feasible solutions for skin trauma cases (e.g., 3D skin printing technology for patients with large-scale burns, which enables patients to avoid rejection and, at the same time, allow the damaged area to grow skin).
The meeting provided critical information for WCBG and all those involved in the project. Overall, the conference provided the foundation for the project's future development.